UCL Breather Results (Luganda)
Kwe kunoonyereza okubuuza oba sikya bulabe okumira eddagala ly’akawuka ka mukenenya okumala ennaku ttaano mu wiiki n’owummulamu ennaku bbiri nga tomira ddagala ku nkomerero ya wiiki.
JCRC Abstracts
UCL Breather Results
It’s a research study asking if it is safe to take HIV medicine for five days a week and have two days off treatment at weekends.
Expanding access to long-acting HIV therapy in low-income and middle-income countries
The global HIV response stands on the threshold of a defining moment. Scientific breakthroughs have ushered in long-acting antiretroviral therapy (ART), which has redefined how HIV can be managed. Injectable formulations, such as cabotegravir–rilpivirine administered every 2 months, have shown high efficacy, safety, and preference across diverse populations and age groups.
